Sanara MedTech (SMTI) Set to Announce Earnings on Tuesday

Sanara MedTech (NASDAQ:SMTI) will release its earnings data after the market closes on Tuesday, November 12th. Persons interested in listening to the company’s earnings conference call can do so using this link.

Sanara MedTech (NASDAQ:SMTI) last issued its quarterly earnings results on Monday, August 12th. The company reported ($0.41) EPS for the quarter. Sanara MedTech had a negative net margin of 9.07% and a negative return on equity of 15.17%. The business had revenue of $20.16 million during the quarter.

Sanara MedTech Stock Performance

Shares of SMTI stock opened at $35.24 on Monday. The stock has a market capitalization of $308.24 million, a PE ratio of -45.18 and a beta of 1.55. The firm has a 50 day moving average of $32.38 and a two-hundred day moving average of $31.20. Sanara MedTech has a 52 week low of $26.00 and a 52 week high of $43.25. The company has a quick ratio of 1.49, a current ratio of 1.80 and a debt-to-equity ratio of 0.35.

About Sanara MedTech

Sanara MedTech Inc, a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers.